Particle and Fibre Toxicology | |
A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs | |
Eva Zschiesche1  Rainer KA Roepke1  Nadja Rohdich1  | |
[1] MSD Animal Health Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany | |
关键词: Dog; Field study; Efficacy; Frontline™ (fipronil); Isoxazoline; Bravecto™ (fluralaner); Ticks; Fleas; | |
Others : 811741 DOI : 10.1186/1756-3305-7-83 |
|
received in 2013-12-18, accepted in 2014-02-24, 发布年份 2014 | |
【 摘 要 】
Background
Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Methods
A randomized, investigator-blinded, multi-centered field study compared the flea- and tick-control efficacy for dogs over a 12-week period with either a single oral dose of Bravecto™ (fluralaner) formulated as a chewable tablet or with three sequential topical Frontline™ (fipronil) treatments. Individual dogs were the experimental unit for ticks and households were the experimental unit for fleas. A total of 108 tick-infested dogs were treated with Bravecto™ (fluralaner) and 54 tick-infested dogs were treated with Frontline™ (fipronil). Dogs in 115 flea-infested households received Bravecto™ (fluralaner) and dogs in 61 flea-infested households received Frontline™ (fipronil). Flea and tick counts were conducted on all dogs at weeks 2, 4, 8, and 12 following initial treatment and efficacy was calculated as the mean percent reduction in tick or flea count at each time point compared with the mean pretreatment initiation count for each treatment group. Additionally, the percentages of tick-free and flea-free households were determined.
Results
At weeks 2, 4, 8, and 12, Bravecto™ (fluralaner) flea-control efficacy in treated households was 99.2%, 99.8%, 99.8%, and 99.9% respectively, while Frontline™ (fipronil) efficacy was 94.1%, 93.0%, 96.0%, and 97.3%, respectively. Bravecto™ (fluralaner) tick-control efficacy on treated dogs at weeks 2, 4, 8, and 12 was 99.9%, 99.9%, 99.7%, and 100%, respectively, and Frontline™ (fipronil) tick efficacy was 97.6%, 93.8%, 100%, and 100%, respectively. Of dogs showing clinical flea allergy dermatitis (FAD) signs at the study start, 85.7% in the Bravecto™ (fluralaner)-treated group and 55.6% in the Frontline™ (fipronil)-treated group were evaluated at each time point as showing no clinical signs of FAD until study completion.
Conclusions
Bravecto™ (fluralaner) administered once orally to dogs in a chewable tablet was highly effective for 12 weeks against fleas and ticks on privately-owned dogs and was significantly non-inferior (ticks) and superior (fleas) in comparison with topical Frontline™ (fipronil) administered 3 times sequentially.
【 授权许可】
2014 Rohdich et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140709071858103.pdf | 168KB | download |
【 参考文献 】
- [1]Coles TB, Dryden MW: Insecticide/acaricide resistance in fleas and ticks infesting dogs and cats. Parasit Vectors 2014, 7:8. BioMed Central Full Text
- [2]Beck S, Schein E, Baldermann C, von Samson-Himmelstjerna G, Kohn B: Tick infestation and tick prophylaxis in dogs in the area of Berlin/Brandenburg – results of a questionnaire study. Berl Munch Tierarztl Wochenschr 2013, 126:69-76.
- [3]Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T: The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Biochem Biophys Res Commun 2010, 391:744-749.
- [4]European Commission, Community register of veterinary medicinal products, Product information Bravecto: Annex 1 Summary of product characteristics. Bruxelles; 2014. http://ec.europa.eu/health/documents/community-register/html/v158.htm webcite
- [5]Gassel M, Wolf C, Noack S, Williams H, Ilg T: The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity. Insect Biochem Mol Biol 2014, 45:111-124.
- [6]Marchiondo AA, Holdsworth PA, Green P, Blagburn BL, Jacobs DE: World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestation on dogs and cats. Vet Parasitol 2007, 145:332-344.
- [7]Farrington CP, Manning G: Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 2009, 9:1447-1454.